Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2019-10-07

FDA Approved: MORPHINE SULFATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA documents a supplemental application for Morphine Sulfate by Hikma Pharmaceuticals USA Inc., likely related to labeling changes for the approved product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MORPHINE SULFATE (MORPHINE SULFATE)

Snippet

SUPPL AP for MORPHINE SULFATE (MORPHINE SULFATE)